ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NP47926 Biologic, Biosimilar’s and Methotrexate Injections

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · tender

Tender information last checkedLast checked 21 Sept 2026, 12:17.

Opportunity overview

Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.

Classification

  • CPV33600000 — Pharmaceutical products
  • CPV33650000 — General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
  • CPV33652000 — Antineoplastic and immunomodulating agents
  • CPV33690000 — Various medicinal products

Lots

  • Adalimumab£68.8m
  • Omalizumab£18.7m
  • Tildrakizumab£4.2m
  • Tocilizumab£46.4m
  • Ustekinumab£68.9m
  • Etanercept£56.8m
  • Golimumab£17.5m
  • Infliximab Intravenous Infusion£31m
  • Infliximab Subcutaneous Injection£18.8m
  • Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device£3.7m
  • Methotrexate (50mg/1ml concentration) Pre-Filled Syringe£2.1k
  • Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection DeviceValue not stated
  • Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe£14.6k

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-077614
Status
active
Main Procurement Category
goods
Procurement Method
open
Procurement Method Details
Open procedure
Has Recurrence
No
Review Details
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.

Legal basis

Id
32014L0024
Scheme
CELEX

Classification

Scheme
CPV
Id
33600000
Description
Pharmaceutical products

Lot Details

Submission Method

electronicSubmission

Selection criteria

Criteria

Criterion 1
Type
suitability
Description
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015

Applies To

supplier
Criterion 2
Type
technical
Description
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the start date. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum
(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the start date should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder’s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.

Applies To

supplier

Techniques

Has Framework Agreement
Yes

Framework Agreement

Maximum Participants
18

Covered By

GPA

Tender Period

Ends
21 Oct 2026, 12:00

Submission terms

Languages

en

Expected award period

Starts
21 Oct 2026, 12:00

Bid Opening

Date
21 Oct 2026, 12:00

Contract terms

Has Electronic Ordering
Yes
Electronic Invoicing Policy
allowed
Has Electronic Payment
Yes

Lots and requirements

Entry 1
Id
8
Title
Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device
Description
Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 2
Id
5
Title
Infliximab Subcutaneous Injection
Description
Supply of infliximab subcutaneous injection to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
18,830,820
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 3
Id
9
Title
Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe
Description
Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
14,565
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 4
Id
6
Title
Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device
Description
Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
3,719,554
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 5
Id
7
Title
Methotrexate (50mg/1ml concentration) Pre-Filled Syringe
Description
Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Syringe to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
2,071
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 6
Id
1
Title
Adalimumab
Description
Supply of adalimumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 7 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
68,840,541
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 7
Id
2
Title
Etanercept
Description
Supply of etanercept to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
56,785,379
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 8
Id
3
Title
Golimumab
Description
Supply of golimumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
17,468,277
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 9
Id
4
Title
Infliximab Intravenous Infusion
Description
Supply of infliximab intravenous infusion to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 6 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
30,991,783
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 10
Id
10
Title
Omalizumab
Description
Supply of omalizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
18,669,166
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 11
Id
12
Title
Tocilizumab
Description
Supply of tocilizumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
46,446,380
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 12
Id
13
Title
Ustekinumab
Description
Supply of ustekinumab to NHS Scotland. The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 9 Framework Participants. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
68,865,598
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed
Entry 13
Id
11
Title
Tildrakizumab
Description
Supply of tildrakizumab to NHS Scotland. The Authority intends to award this Lot as a single supplier framework per product line. Full details of Goods and volumes can be found within the ITT documents.
Has Renewal
Yes
Has Options
No
Status
active

Award criteria

Criteria

Criterion 1
Name
API Sources
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Value

Amount
4,231,882
Currency
GBP

Contract period

Duration In Days
720

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of 24 months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Submission terms

Variant Policy
notAllowed

Items and delivery

Item 1
Id
8
Related Lot
8

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 2
Id
5
Related Lot
5

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 3
Id
9
Related Lot
9

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 4
Id
6
Related Lot
6

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 5
Id
7
Related Lot
7

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 6
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 2
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33600000
Description
Pharmaceutical products

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 7
Id
2
Related Lot
2

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents
Entry 4
Scheme
CPV
Id
33690000
Description
Various medicinal products

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 8
Id
3
Related Lot
3

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 9
Id
4
Related Lot
4

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 10
Id
10
Related Lot
10

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 11
Id
12
Related Lot
12

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 12
Id
13
Related Lot
13

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Item 13
Id
11
Related Lot
11

Additional Classifications

Entry 1
Scheme
CPV
Id
33600000
Description
Pharmaceutical products
Entry 2
Scheme
CPV
Id
33650000
Description
General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
Entry 3
Scheme
CPV
Id
33690000
Description
Various medicinal products
Entry 4
Scheme
CPV
Id
33652000
Description
Antineoplastic and immunomodulating agents

Delivery locations

Entry 1
Region
UKM

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Buyer, suppliers and contacts

Organisation 1
Name
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Id
GB-FTS-179412

Identifier

Legal Name
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

Address

Street Address
1 South Gyle Crescent.
Locality
Edinburgh
Region
UKM
Postal Code
EH12 9EB
Country Name
United Kingdom

Contact

Name
Stephanie McNiven
Telephone
+44 1312756000

Roles

buyer
centralPurchasingBody

Details

Classifications

Entry 1
Scheme
TED_CA_TYPE
Id
BODY_PUBLIC
Description
Body governed by public law
Entry 2
Scheme
COFOG
Id
07
Description
Health
Organisation 2
Name
Sheriff Court House
Id
GB-FTS-324

Identifier

Legal Name
Sheriff Court House

Address

Street Address
27 Chambers Street
Locality
Edinburgh
Postal Code
EH1 1LB
Country Name
United Kingdom

Contact

Telephone
+44 1312252525

Roles

reviewBody

Details

Recorded locations

  • Buyer location · Edinburgh · UKM · EH12 9EB · United Kingdom
  • Delivery location · UKM

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. 088983-2026tender ·